Beam nasdaq
WebSep 8, 2024 · Find the latest SEC Filings data for Beam Therapeutics Inc. Common Stock (BEAM) at Nasdaq.com. WebFind real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Beam Therapeutics Inc (NASDAQ:BEAM) 29.76. Delayed Data. As of Apr 12 -0.33 ...
Beam nasdaq
Did you know?
WebApr 13, 2024 · Beam Therapeutics (NASDAQ:BEAM) has a market capitalization of $2.15 billion and generates $60.92 million in revenue each year. The company earns $-289,090,000.00 in net income (profit) each … WebMar 16, 2024 · Beam Therapeutics has a 1 year low of $27.77 and a 1 year high of $73.27. Beam Therapeutics ( NASDAQ:BEAM - Get Rating) last issued its quarterly earnings …
WebMar 27, 2024 · Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new … Based on analysts offering 12 month price targets for BEAM in the last 3 months. … Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 … Find the latest on option chains for Beam Therapeutics Inc. Common Stock … Find the latest press releases from Beam Therapeutics Inc. Common Stock … Find the latest historical data for Beam Therapeutics Inc. Common Stock … WebNext quarter’s sales forecast for BEAM is $15.61M with a range of $5.00M to $21.30M. The previous quarter’s sales results were $20.04M. BEAM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 42.02% of the time in the same period.
WebBEAM THERAPEUTICS INC. 29.74. at close. +0.42 ( +1.43%) after hours • as of Apr 6, 07:51 PM EDT. 29.89. +0.15 ( +0.50%) 1D. 5D. WebBeam Therapeutics Inc (BEAM) Stock Price & News - Google Finance +91.09 +0.13% +2.33 -0.68 Home BEAM • NASDAQ Beam Therapeutics Inc Follow Share $29.74 After …
WebApr 3, 2024 · Beam Therapeutics Inc. (NASDAQ:BEAM) price closed higher on Friday, March 31, jumping 1.56% above its previous close. A look at the daily price movement shows that the last close reads $30.15, with intraday deals fluctuated between $30.08 and $31.21. The company’s 5Y monthly beta was ticking 1.67.
WebApr 11, 2024 · Beam Global. SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV ... trend wp-t4/077WebMar 20, 2024 · Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which … trendworld san franciscoWebBEAM Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology ... BEAM-102, BEAM-201 and BEAM-301. 26 Landsdowne St. CAMBRIDGE, MA 02139-4216. United States of America +1 ... trend worry free removal toolWebView the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. trendworthWebBEAM Complete Beam Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. temporary event notice rotherWeb2 days ago · Beam Therapeutics Inc. is a biotechnology company. The Company is focused on developing precision genetic medicines based on its base editing technology to provide life-long cures to patients suffering from diseases. Its base editing technology enables a new class of precision genetic medicines that targets a single base in the … trendwyoming.orgWebMar 16, 2024 · Beam Therapeutics has a 1 year low of $27.77 and a 1 year high of $73.27. Beam Therapeutics ( NASDAQ:BEAM - Get Rating) last issued its quarterly earnings data on Tuesday, February 28th. The company reported ($0.54) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.34) by $0.80. trend wrs